Krystal Biotech Receives Orphan Drug Designation from the Japanese MHLW for Beremagene Geperpavec-svdt (B-VEC)
ソース:
Nasdaq GlobeNewswire
/
19 12 2023 07:00:00 America/New_York
N/A
シェアする